These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 25445613)

  • 41. Role of ribomunyl((r)) in the prevention of recurrent respiratory tract infections in adults : overview of clinical results.
    Bousquet J; Oliveri D
    Treat Respir Med; 2006; 5(5):317-24. PubMed ID: 16928145
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A randomized controlled trial of the effect of fluid extract of Echinacea purpurea on the incidence and severity of colds and respiratory infections.
    Grimm W; Müller HH
    Am J Med; 1999 Feb; 106(2):138-43. PubMed ID: 10230741
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Point-of-care C-reactive protein testing to reduce inappropriate use of antibiotics for non-severe acute respiratory infections in Vietnamese primary health care: a randomised controlled trial.
    Do NT; Ta NT; Tran NT; Than HM; Vu BT; Hoang LB; van Doorn HR; Vu DT; Cals JW; Chandna A; Lubell Y; Nadjm B; Thwaites G; Wolbers M; Nguyen KV; Wertheim HF
    Lancet Glob Health; 2016 Sep; 4(9):e633-41. PubMed ID: 27495137
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Intravenous or nebulised magnesium sulphate versus standard therapy for severe acute asthma (3Mg trial): a double-blind, randomised controlled trial.
    Goodacre S; Cohen J; Bradburn M; Gray A; Benger J; Coats T;
    Lancet Respir Med; 2013 Jun; 1(4):293-300. PubMed ID: 24429154
    [TBL] [Abstract][Full Text] [Related]  

  • 45. RCT of montelukast as prophylaxis for upper respiratory tract infections in children.
    Kozer E; Lotem Z; Elgarushe M; Torgovicky R; Cohen R; Cohen HA; Berkovitch M
    Pediatrics; 2012 Feb; 129(2):e285-90. PubMed ID: 22218843
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical effects of erdosteine in the treatment of acute respiratory tract diseases in children.
    Balli F; Bergamini B; Calistru P; Ciofu EP; Domenici R; Doros G; Dragomir D; Gherghina I; Iordachescu F; Murgoci G; Orasanu D; Plesca D; Vaccaro A; Assereto R
    Int J Clin Pharmacol Ther; 2007 Jan; 45(1):16-22. PubMed ID: 17256446
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impact of massive dose of vitamin A given to preschool children with acute diarrhoea on subsequent respiratory and diarrhoeal morbidity.
    Bhandari N; Bhan MK; Sazawal S
    BMJ; 1994 Nov; 309(6966):1404-7. PubMed ID: 7819847
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Influence of OM-85 BV on hBD-1 and immunoglobulin in children with asthma and recurrent respiratory tract infection].
    Liao JY; Zhang T
    Zhongguo Dang Dai Er Ke Za Zhi; 2014 May; 16(5):508-12. PubMed ID: 24857002
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impact of zanamivir on antibiotic use for respiratory events following acute influenza in adolescents and adults.
    Kaiser L; Keene ON; Hammond JM; Elliott M; Hayden FG
    Arch Intern Med; 2000 Nov; 160(21):3234-40. PubMed ID: 11088083
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficacy and safety of inhaled zanamivir in the prevention of influenza in community-dwelling, high-risk adult and adolescent subjects: a 28-day, multicenter, randomized, double-blind, placebo-controlled trial.
    LaForce C; Man CY; Henderson FW; McElhaney JE; Hampel FC; Bettis R; Kudule L; Harris J; Yates P; Tisdale M; Webster A
    Clin Ther; 2007 Aug; 29(8):1579-90; discussion 1577-8. PubMed ID: 17919541
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Use of a polyvalent bacterial lysate in patients with recurrent respiratory tract infections: results of a prospective, placebo-controlled, randomized, double-blind study.
    Rutishauser M; Pitzke P; Grevers G; van Aubel A; Elsasser U; Kämmereit A
    Adv Ther; 1998; 15(6):330-41. PubMed ID: 10351117
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Efficacy of sublingual polyvalent bacterial vaccine (Lantigen B) in children with recurrent respiratory infection: a randomized double-blind controlled clinical trial].
    Chen AH; Chen RC; Zhang CQ; Chen D; Huang S; Lin Y; Zhan J; Zhong N
    Zhonghua Er Ke Za Zhi; 2004 Jun; 42(6):463-4. PubMed ID: 15265442
    [No Abstract]   [Full Text] [Related]  

  • 53. Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting β2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial.
    Wenzel S; Castro M; Corren J; Maspero J; Wang L; Zhang B; Pirozzi G; Sutherland ER; Evans RR; Joish VN; Eckert L; Graham NM; Stahl N; Yancopoulos GD; Louis-Tisserand M; Teper A
    Lancet; 2016 Jul; 388(10039):31-44. PubMed ID: 27130691
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy and tolerability of myrtol standardized in acute bronchitis. A multi-centre, randomised, double-blind, placebo-controlled parallel group clinical trial vs. cefuroxime and ambroxol.
    Matthys H; de Mey C; Carls C; Ryś A; Geib A; Wittig T
    Arzneimittelforschung; 2000 Aug; 50(8):700-11. PubMed ID: 10994153
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Homeopathic medicines for prevention of influenza and acute respiratory tract infections in children: blind, randomized, placebo-controlled clinical trial.
    Siqueira CM; Homsani F; da Veiga VF; Lyrio C; Mattos H; Passos SR; Couceiro JN; Quaresma CH
    Homeopathy; 2016 Feb; 105(1):71-7. PubMed ID: 26828000
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effectiveness of ribosomal fractions of Klebsiella pneumoniae, Streptococcus pneumoniae, Streptococcus pyogenes, Haemophilus influenzae and the membrane fraction of Kp (Ribomunyl) in the prevention of clinical recurrences of infectious rhinitis. Results of a multicenter double-blind placebo-controlled study.
    Serrano E; Demanez JP; Morgon A; Chastang C; Van Cauwenberge P
    Eur Arch Otorhinolaryngol; 1997; 254(8):372-5. PubMed ID: 9332892
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Procalcitonin guided antibiotic therapy and hospitalization in patients with lower respiratory tract infections: a prospective, multicenter, randomized controlled trial.
    Schuetz P; Christ-Crain M; Wolbers M; Schild U; Thomann R; Falconnier C; Widmer I; Neidert S; Blum CA; Schönenberger R; Henzen C; Bregenzer T; Hoess C; Krause M; Bucher HC; Zimmerli W; Müller B;
    BMC Health Serv Res; 2007 Jul; 7():102. PubMed ID: 17615073
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Efficacy and safety of echinacea in treating upper respiratory tract infections in children: a randomized controlled trial.
    Taylor JA; Weber W; Standish L; Quinn H; Goesling J; McGann M; Calabrese C
    JAMA; 2003 Dec; 290(21):2824-30. PubMed ID: 14657066
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Randomized, double-blind, placebo-controlled clinical trial to assess the safety and effectiveness of a novel dual-action oral topical formulation against upper respiratory infections.
    Mukherjee PK; Esper F; Buchheit K; Arters K; Adkins I; Ghannoum MA; Salata RA
    BMC Infect Dis; 2017 Jan; 17(1):74. PubMed ID: 28088167
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Standardised Chinese herbal treatment delivered by GPs compared with individualised treatment administered by practitioners of Chinese herbal medicine for women with recurrent urinary tract infections (RUTI): study protocol for a randomised controlled trial.
    Flower A; Harman K; Lewith G; Moore M; Bishop FL; Stuart B; Lampert N
    Trials; 2016 Jul; 17():358. PubMed ID: 27460108
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.